Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edmond M Kwan

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 23, 2021
Considerations on the identification and management of metastatic prostate cancer patients with DNA repair gene alterations in the Canadian contextMichael P Kolinsky, Karen Y Niederhoffer, Edmond M Kwan, et al.
Internal Medicine Journal|February 20, 2019
Impact of access to novel therapies on the initial management of castrate-resistant prostate cancer: an Australian multicentre studyEdmond M Kwan, Marie C Semira, Alice R T Bergin, et al.
European Urology Focus|August 3, 2020
Prognostic Impact of Total Plasma Cell-free DNA Concentration in Androgen Receptor Pathway Inhibitor-treated Metastatic Castration-resistant Prostate CancerHeidi Fettke, Edmond M Kwan, Patricia Bukczynska, et al.
JCO Clinical Cancer Informatics|July 25, 2023
Multi-Omic Integration of Blood-Based Tumor-Associated Genomic and Lipidomic Profiles Using Machine Learning Models in Metastatic Prostate CancerShikai Fang, Shandian Zhe, Hui-Ming Lin, et al.
Clinical Genitourinary Cancer|September 26, 2017
Impact of Granulocyte-colony Stimulating Factor on Bleomycin-induced Pneumonitis in Chemotherapy-treated Germ Cell TumorsEdmond M Kwan, Sophie Beck, Eitan Amir, et al.
Asia-Pacific Journal of Clinical Oncology|January 31, 2022
Beyond cabazitaxel: Late line treatments in metastatic castration resistant prostate cancer: A retrospective multicentre analysisGrace Chazan, Angelyn Anton, Shirley Wong, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 12, 2026
Variable cellular and radiobiological effects of [<sup>177</sup>Lu]Lu-PSMA-I&T in patient-derived models of prostate cancerIsabel M Everard, Michael J de Veer, Edmond M Kwan, et al.
Asia-Pacific Journal of Clinical Oncology|October 31, 2017
Precision oncology using a clinician-directed, tailored approach to molecular profilingMichael Lam, Ben Tran, Sophie Beck, et al.
Biotechniques|July 14, 2020
Analytical validation of an error-corrected ultra-sensitive ctDNA next-generation sequencing assayHeidi Fettke, Jason A Steen, Edmond M Kwan, et al.
The Prostate|July 13, 2021
Independent prognostic impact of plasma NCOA2 alterations in metastatic castration-resistant prostate cancerHeidi Fettke, Edmond M Kwan, Patricia Bukczynska, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 23, 2021
Considerations on the identification and management of metastatic prostate cancer patients with DNA repair gene alterations in the Canadian contextMichael P Kolinsky, Karen Y Niederhoffer, Edmond M Kwan, et al.
Internal Medicine Journal|February 20, 2019
Impact of access to novel therapies on the initial management of castrate-resistant prostate cancer: an Australian multicentre studyEdmond M Kwan, Marie C Semira, Alice R T Bergin, et al.
European Urology Focus|August 3, 2020
Prognostic Impact of Total Plasma Cell-free DNA Concentration in Androgen Receptor Pathway Inhibitor-treated Metastatic Castration-resistant Prostate CancerHeidi Fettke, Edmond M Kwan, Patricia Bukczynska, et al.
JCO Clinical Cancer Informatics|July 25, 2023
Multi-Omic Integration of Blood-Based Tumor-Associated Genomic and Lipidomic Profiles Using Machine Learning Models in Metastatic Prostate CancerShikai Fang, Shandian Zhe, Hui-Ming Lin, et al.
Clinical Genitourinary Cancer|September 26, 2017
Impact of Granulocyte-colony Stimulating Factor on Bleomycin-induced Pneumonitis in Chemotherapy-treated Germ Cell TumorsEdmond M Kwan, Sophie Beck, Eitan Amir, et al.
Asia-Pacific Journal of Clinical Oncology|January 31, 2022
Beyond cabazitaxel: Late line treatments in metastatic castration resistant prostate cancer: A retrospective multicentre analysisGrace Chazan, Angelyn Anton, Shirley Wong, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 12, 2026
Variable cellular and radiobiological effects of [<sup>177</sup>Lu]Lu-PSMA-I&T in patient-derived models of prostate cancerIsabel M Everard, Michael J de Veer, Edmond M Kwan, et al.
Asia-Pacific Journal of Clinical Oncology|October 31, 2017
Precision oncology using a clinician-directed, tailored approach to molecular profilingMichael Lam, Ben Tran, Sophie Beck, et al.
Biotechniques|July 14, 2020
Analytical validation of an error-corrected ultra-sensitive ctDNA next-generation sequencing assayHeidi Fettke, Jason A Steen, Edmond M Kwan, et al.
The Prostate|July 13, 2021
Independent prognostic impact of plasma NCOA2 alterations in metastatic castration-resistant prostate cancerHeidi Fettke, Edmond M Kwan, Patricia Bukczynska, et al.
Pageof 6